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Introduction {#sec005}
============

Diverticulosis of the small intestines, other than Meckel's diverticulum, is very rare. Its prevalence has been estimated at just 0.01%--2.3% in clinical studies, but rising to 4.6% in an autopsy study \[[@pone.0234417.ref001]\]. The most common site of small intestinal diverticulosis is the duodenum, followed by the jejunum and ileum \[[@pone.0234417.ref002]\]. Although haemorrhage is the most challenging and potentially fatal complication, it can be difficult to diagnose, especially when affecting the jejunum and ileum \[[@pone.0234417.ref001], [@pone.0234417.ref003], [@pone.0234417.ref004]\]. Obscure gastrointestinal bleeding due to diverticular disease occurs more often in Eastern (6.8%) than in Western (1.2%) populations \[[@pone.0234417.ref005]\].

Enteroscopy is the current primary endoscopic diagnostic and therapeutic approach for obscure gastrointestinal bleeding \[[@pone.0234417.ref006]\] including jejunoileal diverticular haemorrhage (JIDH). Alternative non-endoscopic diagnostic tools, including small bowel follow-through studies, computed tomography (CT), angiography and technetium red cell-tagged scans, are used when enteroscopy is not available \[[@pone.0234417.ref001]\]. Even resorting to exploratory laparotomy may fail to identify the site of bleeding \[[@pone.0234417.ref001]\]. Currently, surgical treatment after radiological examination remains the standard of care for JIDH \[[@pone.0234417.ref004], [@pone.0234417.ref007]--[@pone.0234417.ref010]\]. However, with the advent and popularisation of device-assisted endoscopic techniques (e.g. double-balloon enteroscopy), both endoscopic diagnosis and treatment have become possible \[[@pone.0234417.ref004], [@pone.0234417.ref011]--[@pone.0234417.ref015]\]. To date, comparisons of the different outcomes from surgical and non-surgical modalities are lacking.

In the present retrospective study, which follows on from earlier research \[[@pone.0234417.ref004]\], we reviewed the clinical features, diagnostic methods, treatments and outcomes of JIDH at our institute over the past two decades. We also report on current practice at our hospital and review the surgical and non-surgical management of this rare disease.

Materials and methods {#sec006}
=====================

Study design {#sec007}
------------

We conducted a retrospective review of the medical records of patients with small intestinal diverticular haemorrhage who were diagnosed and treated at Changhua Christian Hospital, Changhua, Taiwan. The study covered two decades from 1^st^ January 2000 to 31^st^ July 2019. The study protocol was approved by the Institutional Review Board of Changhua Christian Hospital (No. 190814), and documentation of informed consent was waived because the study was conducted retrospectively.

Participants and data collection {#sec008}
--------------------------------

We included patients diagnosed with small intestinal diverticular haemorrhage (ICD-9 562.03 or ICD-10 K57.11). Any patient with bleeding from a duodenal diverticulum or a Meckel's diverticulum was excluded. Some of the patients in the present data set have been included in an earlier report \[[@pone.0234417.ref004]\]. For the purpose of our analysis, JIDH was diagnosed by the following criteria: (1) the presence of active bleeding at surgery or endoscopy; (2) active contrast extravasation on angiography or CT scan or (3) evidence of stigmata of recent haemorrhage at surgery, endoscopy or radiological examination in the absence of bleeding from other gastrointestinal sites.

Data from the endoscopic database and medical records at our hospital were reviewed and extracted. The following characteristics of patients with JIDH were extracted from the database, including sex, age, underlying disease (e.g. hypertension, diabetes mellitus, chronic renal failure, ischaemic heart disease and cerebrovascular disease), oral medication use (e.g. non-steroidal anti-inflammatory or antiplatelet drugs) haemoglobin concentration on admission, length of hospitalisation, blood transfusion requirements (total units), time from symptoms onset to diagnosis, follow-up duration from diagnosis to the last visit, symptoms and signs, presence of hypovolemic shock on admission, rebleeding events and mortality. Included diagnostic methods were CT scan, endoscopy, angiography, small bowel flow-through and surgery. All of the CT scans in the present study were performed with CT angiography protocol. Included primary treatments were defined as surgical, radiological, endoscopic or supportive. The methods of enteroscopy include push endoscope (SIF-Q140, Olympus Co., Japan) performed in 5 cases before 2004, and double-balloon endoscope (EN-450P5 or EN-450T5, Fujinon Co., Japan) performed in the rest of the cases after 2004 in our institution.

Outcomes {#sec009}
--------

The primary outcome was the change in diagnostic or therapeutic management of JIDH at our institution over the last 20 years. Specifically, we compared the 2000--2009 period and the 2010--2019 period. The secondary outcomes were to compare the length of hospitalisation, the complication rate, the long-term rebleeding rate, the bleeding-related survival rate and the non-bleeding-related survival rate between treatment approaches.

Statistical analysis {#sec010}
--------------------

The acquired data were organised with Microsoft Excel and all statistical analyses were performed using MedCalc for Windows, version 18.11 (MedCalc Software, Ostend, Belgium; [https://www.medcalc.org](https://www.medcalc.org/)). Quantitative data are presented as means ± standard deviations. Statistical differences were assessed with the chi-square test for categorical variables or the student *t-*test for continuous variables. Kaplan--Meier survival curves were drawn to compare rebleeding rates between the surgically and non-surgically treated groups. Results were considered statistically significant for *p*-values of \<0.05.

Results {#sec011}
=======

Clinical features and characteristics of jejunoileal diverticular haemorrhage {#sec012}
-----------------------------------------------------------------------------

The clinical features and presentations of the 68 patients with JIDH who met our inclusion criteria are listed in [Table 1](#pone.0234417.t001){ref-type="table"}; the average age was 72.41 years (range 48--94 years) and 33 were male (48.53%). The mean interval from initial symptom onset to diagnosis was 31.06 days (range, 0--1089 days; median 5 days). Clinical presentations included tarry stool (83.82%), bloody stool (47.06%), shock (27.94%) and coffee ground vomitus (2.94%). The mean haemoglobin level at presentation was 7.70 g/L. The mean hospital stay was 14.97 days (range, 3--84 days; median, 10.5 days), with patients receiving a mean red blood cell transfusion volume of 11.27 units. The mean follow-up duration was 1589.56 days.

10.1371/journal.pone.0234417.t001

###### Characteristics and clinical presentations of participants.

![](pone.0234417.t001){#pone.0234417.t001g}

  Clinical Variables                          Data
  ------------------------------------------- -------------------
  Sex (male/female)                           33/35
  Age (years, mean ± SD)                      72.41 ± 8.64
  Haemoglobin (g/L, mean ± SD)                7.70 ± 1.87
  Length of Hospital Stay (days, mean ± SD)   14.97 ± 13.18
  RBC Transfusion (units, mean ± SD)          11.27 ± 10.98
  Time to Diagnosis (days, mean ± SD)         31.06 ± 138.48
  Follow-up Duration (days, mean ± SD)        1589.56 ± 1547.73
  Symptoms and Signs, n (%)                   
   Tarry Stool                                57 (83.82%)
   Bloody Stool                               32 (47.06%)
   Shock                                      19 (27.94%)
   Coffee Ground Vomitus                      2 (2.94%)
  Utilised Diagnostic Procedures, n (%)       
   CT Scan                                    60 (88.24%)
   Enteroscopy                                39 (57.35%)
   Angiography                                14 (20.59%)
   Small bowel follow-through                 9 (13.24%)
   Diagnostic Surgery                         2 (2.94%)
  Yields of Diagnostic Procedures, n (%)      
   CT Scan                                    21/60 (35.00%)
   Enteroscopy                                34/39 (87.18%)
   Angiography                                2/14 (14.29%)
   Small bowel follow-through                 8/9 (88.89%)
   Diagnostic Surgery                         2/2 (100.00%)
  Rebleeding, n (%)                           12 (17.65%)
  Bleeding-related Mortality, n (%)           1 (1.47%)

Abbreviations: CT, computed tomography; GI, gastrointestinal; RBC, red blood cell; SD, standard deviation.

CT scan was the most commonly utilised diagnostic tool for JIDH (N = 60; 88.24%), followed by enteroscopy (N = 39; 57.35%), angiography (N = 14; 20.59%), small bowel barium follow-through (N = 9; 13.24%) and surgery (N = 2; 2.94%). The corresponding diagnostic yields for JIDH were 35.00% (21/60), 87.18% (34/39), 14.29% (2/14), 88.89% (8/9) and 100.00% (2/2), respectively. Rebleeding events were noted in 12 cases (17.65%). All-cause mortality was reported for 8 patients (11.76%), all of whom were older than 71 years; there was only one bleeding-related death (1.47%), with sepsis, malignancy, acute myocardial infarction, respiratory failure and cerebrovascular accident being the other causes.

Comparison between surgically and non-surgically treated groups {#sec013}
---------------------------------------------------------------

The clinical features of 22 patients initially treated surgically were compared to those of 46 patients initially treated non-surgically ([Table 2](#pone.0234417.t002){ref-type="table"}). In the surgical group, hospital stays were longer (24.68 ± 17.40 vs. 10.33 ± 7.02 days, *p* \< 0.0001), red blood cell transfusion volumes were higher (15.09 ± 12.15 vs. 8.96 ± 9.91 units, *p* = 0.0302) and rebleeding rates were lower (0% vs. 26.09%, *p* = 0.0088; [Fig 1](#pone.0234417.g001){ref-type="fig"}).

![Comparison of rebleeding rates between patients treated surgically and non-surgically (*p* = 0.0088).](pone.0234417.g001){#pone.0234417.g001}

10.1371/journal.pone.0234417.t002

###### Clinical features of the surgical and non-surgical groups.

![](pone.0234417.t002){#pone.0234417.t002g}

  Clinical Features                           Surgery (N = 22)   Non-Surgical Intervention (N = 46)   *p*-value
  ------------------------------------------- ------------------ ------------------------------------ ------------
  Age (years, mean ± SD)                      72.55 ± 8.26       72.35 ± 8.74                         0.9287
  Haemoglobin (g/L, mean ± SD)                7.36 ± 2.04        7.86 ± 1.79                          0.3069
  Length of Hospital Stay (days, mean ± SD)   24.68 ± 17.40      10.33 ± 7.02                         \<0.0001\*
  RBC Transfusion (units, mean ± SD)          15.09 ± 12.15      8.96 ± 9.91                          0.0302\*
  Time to Diagnosis (days, mean ± SD)         9.77 ± 25.55       41.24 ± 167.09                       0.3847
  Symptoms and Signs, n (%)                                                                           
   Tarry Stool                                15 (82.14%)        42 (91.30%)                          0.0162\*
   Bloody Stool                               17 (64.29%)        15 (32.61%)                          0.0006\*
   Shock                                      12 (32.14%)        7 (15.22%)                           0.0008\*
   Coffee Ground Vomitus                      1 (3.57%)          1 (2.17%)                            0.5909
  Rebleeding, n (%)                           0 (0.00%)          12 (26.09%)                          0.0088\*
  Bleeding-related Mortality, n (%)           0 (0.00%)          1 (2.17%)                            0.4892

Abbreviations: RBC, red blood cell; SD, standard deviation.

Concerning the signs and symptoms, more patients presented with tarry stools in the non-surgical group than in the surgical group (91.30% vs. 82.14%, *p* = 0.0162), but patients in the surgical group had higher proportions of bloody stools (64.29% vs. 32.61%, *p* = 0.0006) and haemorrhagic shock (32.14% vs. 15.22%, *p* = 0.0008). All-cause mortality rates were 13.33% (N = 6) in the non-surgical group and 8.70% (N = 2) in the surgical group, with similar survival curves (*p* = 0.4511; [Fig 2](#pone.0234417.g002){ref-type="fig"}).

![Comparison of survival curves between patients treated surgically and non-surgically (*p* = 0.4511).](pone.0234417.g002){#pone.0234417.g002}

When comparing initial endoscopic treatment with initial surgical treatment, there were some notable differences. Surgery was used significantly more often in patients with bloody stools (*p* = 0.0013) and haemorrhagic shock (*p* = 0.0304), with this group also having longer hospital stays (*p* = 0.0019). By contrast, the rebleeding rate was higher in the endoscopic treatment group (*p* = 0.0048).

Choice of diagnostic tools and treatments before 2009 and after 2010 {#sec014}
--------------------------------------------------------------------

From 3 to 2009, with a total number of 35 patients, enteroscopy, CT, angiography, surgery and small bowel follow-through were performed diagnostically in 22 (34.4%), 29 (45.3%), 8 (12.5%), 2 (3.1%) and 4 (6.3%) cases, respectively. The corresponding numbers from 2010 to 2019 in 33 patients were 18 (30.0%), 31 (51.7%), 6 (10.0%), 0 (0.0%) and 5 (8.3%), respectively ([Table 3](#pone.0234417.t003){ref-type="table"}). The choice of diagnostic tool was comparable between each period (*p* = 0.6149) ([Fig 3A](#pone.0234417.g003){ref-type="fig"}). From 2000 to 2009, surgery, radiology, medical therapy and endoscopy were used initially in 13 (37.1%), 0 (0.0%), 12 (34.3%) and 10 (28.6%) cases, respectively; the corresponding numbers from 2010 to 2019 were 9 (27.3%), 1 (3.0%), 14 (42.4%) and 9 (27.3%), respectively ([Table 3](#pone.0234417.t003){ref-type="table"}). The primary treatment choice did not change significantly between the two periods (*p* = 0.5984) ([Fig 3B](#pone.0234417.g003){ref-type="fig"}).

![Clinical management of jejunoileal diverticular haemorrhage before 2009 and after 2010.\
(A) Choice of diagnostic tool for jejunoileal diverticular haemorrhage before 2009 and after 2010. (B) Choice of treatment for jejunoileal diverticular haemorrhage before 2009 and after 2010.](pone.0234417.g003){#pone.0234417.g003}

10.1371/journal.pone.0234417.t003

###### Changes in the clinical management of jejunoileal diverticular haemorrhage before 2009 and after 2010.

![](pone.0234417.t003){#pone.0234417.t003g}

  Diagnosis         pre-2009     post-2010       Treatments      pre-2009     post-2010
  ----------------- ------------ --------------- --------------- ------------ ------------
  **Enteroscopy**   22 (34.4%)   18 (30.0%)      **Surgery**     13 (37.1%)   9 (27.3%)
  **CT Scan**       29 (45.3%)   31 (51.7%)      **Radiology**   0 (0.0%)     1 (3.0%)
  **Angiography**   8 (12.5%)    6 (10.0%)       **Medical**     12 (34.3%)   14 (42.4%)
  **Surgery**       2 (3.1%)     0 (0.0%)        **Endoscopy**   10 (28.6%)   9 (27.3%)
  **SBFT**          4 (6.3%)     5 (8.3%)                                     
  ***p*-value**     0.6149       ***p*-value**   0.5984                       

Abbreviations: CT, computed tomography; SBFT, Small bowel follow-through.

The outcomes of JIDH after endoscopic and supportive treatments were also studied. The risks of needing subsequent diverticular resection after failed initial endoscopic or supportive treatments were 5.26% and 11.54%, respectively (*p* = 0.4700). Moreover, the risks of rebleeding (*p* = 0.5288) and of all-cause mortality (*p* = 0.6820) were similar in the groups receiving endoscopic and supportive treatments ([Table 4](#pone.0234417.t004){ref-type="table"}).

10.1371/journal.pone.0234417.t004

###### The risks of subsequent surgery, rebleeding event and all-cause mortality after initial endoscopic or supportive treatments.

![](pone.0234417.t004){#pone.0234417.t004g}

                            Endoscopy (N = 19)   Supportive therapy (N = 26)   *p-*value
  ------------------------- -------------------- ----------------------------- -----------
  Subsequent surgery        1                    3                             0.4700
  No subsequent surgery     18                   23                            
  Subsequent surgery rate   5.26%                11.54%                        
  Rebleeding                6                    6                             0.5288
  Non-rebleeding            13                   20                            
  Rebleeding rate           31.58%               30.00%                        
  Mortality (all-cause)     3                    3                             0.6820
  Alive                     16                   23                            
  Mortality rate            15.79%               11.54%                        

Discussion {#sec015}
==========

JIDH is a rare and potentially fatal disease that can be difficult to identify because it is located beyond the reach of regular diagnostic procedures. Previous reports have mainly focused on radiological diagnosis and surgical management, and although developments in endoscopic techniques should probably have been associated with a change in management, there are no clear data on whether this has occurred. We therefore aimed to report our experience with the management and follow-up of JIDH over recent decades. To the best of our knowledge, this is the largest case series of JIDH in the 21^st^ century. Our major findings confirm several clinically relevant features of the disease, whilst also showing that there has been little change in either the diagnostic or the treatment approach between 2000 and 2019.

Clinically, although there was no sex predominance, most patients were elderly. Patients also tended to have low haemoglobin levels and required blood transfusions (N = 65; 95.6%), consistent with the haemorrhagic pathology. Despite the known difficulties in diagnosis, the time from symptom onset to diagnosis was relatively short (median, 5 days). The most common symptoms and signs were tarry stools (83.82%), but bloody stools and shock were present in 47.06% and 27.94%, respectively. These presentations may have raised the clinical suspicion of JIDH.

CT was the most commonly used diagnostic tool for JIDH, although two patients received emergency surgery for massive bleeding, with the diagnosis of JIDH made postoperatively. Surgery yielded 100% diagnostic accuracy, while enteroscopy (87.18%) and small bowel flow-through (88.89%) showed similar performances. Although rebleeding events occurred in 17.65% of patients, bleeding-related mortality was very rare compared with 8.33%--20.59% reported in previous studies, with only one case in our study \[[@pone.0234417.ref010], [@pone.0234417.ref016]\]. We therefore have reservations that the disease is necessarily associated with high mortality, particularly due to delayed diagnosis \[[@pone.0234417.ref017]\].

Surgical interventions were associated with longer hospital stays and greater blood transfusion volumes, but with lower rebleeding rates. Although hospital stays and blood transfusion reflect disease severity, they also resulted from the surgical intervention. Of note, the rebleeding rate was zero after surgical resection, which should be expected because the lesion is removed; by contrast, non-surgical treatments only seek to achieve haemostasis ([Fig 1](#pone.0234417.g001){ref-type="fig"}). Furthermore, based on its multifactorial and insidious pathogenesis, a diverticulum develops chronically \[[@pone.0234417.ref018]\], and most of the patients present JIDH at an old age. Therefore, in elderly patients, it is less likely to have another bleeding event of JIDH. Tarry stools were mostly presented in the non-surgical group, while bloody stools and shock were mainly present in the surgical group, which are broadly consistent with the management approaches. In [Fig 2](#pone.0234417.g002){ref-type="fig"}, the survival curve of surgically treated patients seemed to be above that of non-surgically treated patients; however, the two curves were not statistically difference, indicating comparable all-cause mortality.

When comparing the two decades at our institution, we noted that there had been little change in the diagnostic tools and treatments that were used ([Table 3](#pone.0234417.t003){ref-type="table"} and [Fig 3](#pone.0234417.g003){ref-type="fig"}). We had introduced deep enteroscopy early, in 2004, for the treatment of small intestinal haemorrhage at our institution \[[@pone.0234417.ref019]--[@pone.0234417.ref021]\]. This had allowed patients to be treated beyond the choice of surgery, dependent on each situation, which may explain why treatment has not changed at our institution.

Although there were no statistical differences between endoscopic and supportive approaches in the rates of subsequent surgery, rebleeding or all-cause mortality, we found a relatively low rate of subsequent surgery in patients treated endoscopically (5.26%) than in patients treated with supportive care (11.54%). We therefore suggest that endoscopic treatments are probably superior to supportive therapy because they achieve haemostasis at higher rates. It is possible that these results would become statistically significant with a larger sample.

Previous studies have indicated that jejunal diverticular haemorrhage has a high mortality rate after conservative treatment (80%) compared with surgical treatment (14%) \[[@pone.0234417.ref022]\]. However, this based on a summary published in 1969 when endoscopic technology was still in its infancy \[[@pone.0234417.ref016]\]. Little is known about the changes in management and natural course of this rare disease since the full range of enteroscopy has been introduced. Clinicians today have options other than surgery or supportive therapy, and our results provides information about experiences with all treatment options in a long-term and relatively large sample of patients with JIDH.

Currently, the gold standard of diagnosis and treatment are small bowel flow-through radiography followed by limited surgical resection of the involved intestine \[[@pone.0234417.ref008]\]. However, small bowel flow-through was only performed in a minority of patients with JIDH, and it was less useful than either CT or enteroscopy. Although there was no rebleeding associated with surgery, which was reserved for more severe cases, this approach was highly invasive and associated with significant healthcare expenditure. This included longer hospitalisations (double) and larger blood transfusion volumes.

Despite the risk of rebleeding, mortality after initial non-surgical treatment was very rare, suggesting that long-term outcomes could be acceptable in JIDH. Consistent with our previous report \[[@pone.0234417.ref004]\], approximately two-thirds of patients were treated non-surgically, which may be due to improvements in diagnosis and treatment over recent decades. Although we still advocate surgery as the standard treatment, endoscopy clearly has a role as an alternative that may be appropriate in certain clinical situations. Indeed, surgical intervention should be preferred for the relatively young or those with low haemoglobin levels, bloody stools and haemorrhagic shock; by contrast, non-surgical interventions may be favoured for older patients and those with less severe disease or contraindications to surgery. Of course, patients receiving non-surgical treatments will need to be informed of the possibility of subsequent surgical intervention if non-surgical treatments fail.

There are some limitations in the present study. Most notably, this was a retrospective analysis, and the clinical evaluations, diagnoses and treatments were operator dependent and could not be standardised. Although the case number was adequate for gaining a better understanding of JIDH, it was insufficient to allow statistical power for subgroup analysis (e.g. comparison of outcomes between endoscopic and supportive therapies).

In conclusion, we have described our experiences with the management of JIDH over the last two decades, during which we found no significant changes in diagnostic or treatment approaches. In patients with gastrointestinal bleeding, after excluding upper and lower gastrointestinal haemorrhage, enteroscopy can be very helpful. We recommend that surgery should remain the treatment of choice for JIDH, but our experience also indicates that endoscopic treatment could increasingly be considered as an alternative option in certain patient groups.
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If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0234417.r002

Author response to Decision Letter 0

1 May 2020

Chun Chieh Yeh, M.D., Ph.D.

Academic Editor

PLOS ONE

Dear Editor,

We appreciate your editorial comments, as well as those of the reviewers, concerning our manuscript. Based on these comments, we have made several revisions to our manuscript, which is resubmitted for your consideration. The manuscript has also been revised according to the PLOS ONE\'s style requirements. If there is anything needing to be further improved, please do not hesitate to inform us at your earliest convenience. Your assistance is highly appreciated. We look forward to your message.

The followings are point-by-point responses to the comments.

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>.

Response: The manuscript has been revised per the journal's requirement. If there is anything further required, please do not hesitate to inform us. We are very happy to cooperate.

2\. We note that you have included the phrase "data not shown" in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

Response: We understand the policy of the journal. All authors agreed to provide de-identified raw data as supporting information from which all of the results were derived. The phrase "data not shown" has been removed.

Reviewers\' comments:

Reviewer\'s Responses to Questions

Comments to the Author

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Partly

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: No

Response: All authors agreed to provide de-identified raw data as supporting information from which all of the results were derived.

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

5\. Review Comments to the Author

Reviewer \#1:

To the authors,

This manuscript is a very interesting and valuable study in the GI field. As we know, the jejunoileal diverticular bleeding is not common in the clinical practice, especially in the Western countries. By the contrast, the jejunoileal diverticular bleeding is more common in the Asian countries compared to the Western countries.

I have some questions for your manuscript

Q1. In the section: Enteroscopy is the primary diagnostic approach for jejunoileal diverticular haemorrhage (JIDH) and includes endoscopy of the small intestines \[6\], small bowel follow-through studies, computed tomography (CT), angiography and technetium red cell-tagged scans that are beyond the reach of esophagogastroduodenoscopy and colonoscopy \[1\]. Its meaning is not very clear to readers. Can you rewrite them ?

Response: All authors thank the reviewer's correction. We apologize for the misleading and somewhat mistaken sentence. The sentence has been rewritten as follows, "Enteroscopy is the current primary endoscopic diagnostic and therapeutic approach for obscure gastrointestinal bleeding \[6\] including jejunoileal diverticular haemorrhage (JIDH). Alternative non-endoscopic diagnostic tools, including small bowel follow-through studies, computed tomography (CT), angiography and technetium red cell-tagged scans, are used when enteroscopy is not available \[1\]," as in line 49-53.

Q2. Your manuscript mentioned \"Investigation revealed coexisting gastrointestinal diverticula in the duodenum (23.53%) and colon (14.71%)\". Can I ask the diagnostic tool for your coexisting gastrointestinal diverticula?

Response: We thank the reviewer for the question. Because of higher incidence as well as anatomical accessibility of the gastro-duodenal and colonic hemorrhage, patients with gastrointestinal bleeding will received either esophagogastroduodenoscopy or colonoscopy before further investigation for small intestinal bleeder. Hence, those duodenal and colonic diverticula were found by esophagogastroduodenoscopy or colonoscopy. Please find line 116 where we have added a sentence to address this concern.

Q3. In your manuscript, you said that deep enteroscopy was introduced at your institution in 2004 for the treatment of small intestinal haemorrhage. What is your reason for the decreased rate in diagnostic enteroscopy after 2010? Moreover, what is your diagnostic enteroscopy before 2004?

Response: The authors thank the reviewer for the question. The management of obscure GI bleeding changed over the past two decades. For example, in the AGA medical position statement (Gastroenterology. 2000 Jan;118(1):197-201. DOI: 10.1016/s0016-5085(00)70429-x), there was no role of CT scan in diagnosis/management for OGIB.

The situation changed after the introduction of deep enteroscopy. In fact, deep enteroscopy was introduced to Taiwan and our institution in 2004. Before 2004, we performed push endoscopy which could only visualize the proximal jejunum at most. As the resolution and feasibility of computed tomography angiography (CTA) improved (Yen HH et al. World J Gastroenterol. 2012 Feb 21;18(7):692-7. doi: 10.3748/wjg.v18.i7.692), patients usually received non-invasive diagnostic procedure such as CTA first, followed by invasive diagnostic procedures such as enteroscopy.

Q4. In the diagnostic modalities of jejunoileal diverticula, your described the total number was 64 before 2009, and 60 after 2010. Does the number mean the patients numbers? (your total enrolled patients were 68)

Response: All authors thank the reviewer for the correction. The number "64" and "60" were the sums of the counts of the diagnostic procedures. They were not referred to as the number of patients, and they were therefore negligible. We would like to remove the row of the table in order not to cause confusion as well as unnecessity. The total numbers of patients before 2009 and after 2010 were 35 and 33, respectively, which we would like to add in line 153 and 156.

Reviewer \#2:

This is a retrospective study about jejunoileal diveticular hemorhage. the study included small number of patients- 68 only.

some major revisions need to be done:

1- the abstract should be fragmented into introduction, methods, results and conclusion- in breif as the whole article.

Response: The authors thank the reviewer for the correction. The abstract has been rewritten as a structured abstract.

2- in the introdcution section: enteroscopy is an endoscopy of the small bowel and does not include small bowel follow through, CT scan, angiography and Tc RBC scan- these are a different radiological dignostic tools, and not as written that are part of the enteroscopy.

Response: All authors thank the reviewer's correction. We apologize for the misleading and somewhat mistaken sentence. The sentence has been rewritten as follows, "Enteroscopy is the current primary endoscopic diagnostic and therapeutic approach for obscure gastrointestinal bleeding \[6\] including jejunoileal diverticular haemorrhage (JIDH). Alternative non-endoscopic diagnostic tools, including small bowel follow-through studies, computed tomography (CT), angiography and technetium red cell-tagged scans, are used when enteroscopy is not available \[1\]," as in line 49-53.

3- following the introduction, methods and materials should be written before the results.

Response: The authors thank the reviewer for the correction. The "materials and methods" section has been shifted right after the "introduction" section.

4- the most utilised diagnostic procedure was CT scan according to the authors- the authors means CT scan or CT angiography scan? and wether CT angiography was used as a diagnostic procedure.

Response: All authors thank the reviewer for the question. In our institution, abdominal CT scan indicated for GI bleeding is conducted with CT angiography protocol (Yen HH et al. World J Gastroenterol. 2012 Feb 21;18(7):692-7. DOI: 10.3748/wjg.v18.i7.692), because non-contrast CT scan is not helpful. Therefore, in the present study, all CT scans were performed as CT angiography. We did not clarify this point in the manuscript and we believe the same question would be raised by readers. We would like to add a sentence, "All of the CT scans in the present study were performed with CT angiography protocol", in line 89 and 90, to avoid such concern.

5- what were the findings on the different diagnostic tools?

Response: Different diagnostic tools in the present study included enteroscopy, CT scan (CT angiography), angiography, surgery, and small bowel flow-through study. By enteroscopy, bleeders or lesions could be directly visualized with in small intestines. CTA scan is able to diagnose and localize the nature of the bleeder, such as tumor or diverticulum. Angiography is used to localize the bleeder with contrast extravasation, yet with inferior diagnostic capability to outline non-vascular lesions or structures. Exploratory surgery was commonly conducted under emergency and could directly expose the lesions followed by surgical repair. Finally, small bowel flow-through study utilizes contrast medium to delineate the intestinal lumen, and therefore could facilitate diagnosis of bowel structural abnormality such as diverticulum, unable to confirm the presence of bleeding or the nature of the bleeder.

6- 22 patiens were treated initially by surgical means- but afterward, surgery was used in total of 7 patients for diagnosis\... this means that 15 patients actually underwent other dianostic procedures- what are these procedures? and what was the indication for operation?

Response: The authors thank the reviewer's comment. Overall, 22 patients were treated with surgery, and with all due respect, diagnostic surgery had been performed in 2, but not 7, patients. In the other 20 patients, these diagnostic procedures included CT scan in 13 patients, angiography in 5 patients, and endoscopy in 2 patients. The indications for surgery were jejunoileal diverticular bleeding based on individualized clinical situations.

7- table 3 should include the total number of patients before 2009 and total number after.

Response: The authors thank the reviewer's suggestion. The total numbers of patients before 2009 and after 2010 were 35 and 33, respectively. However, a patient could have undergone more than one diagnostic procedures. We are afraid that if the total number of patient be written in Table 3, the readers might be confused with the total number of the patients or the procedures. Therefore, please allow us to remove the total number from Table 3. Alternatively, we would like to add the total number of patients in the text, as in line 153 and 156.

Thank you for the opportunity to resubmit this manuscript for consideration of publication in PLOS ONE. If you have any questions or comments regarding this manuscript, please do not hesitate to contact us by mail at our correspondence address, by fax at +886-4-7228289, by telephone at +886-4-7238595ext5501, or by e-mail at <91646@cch.org.tw>

Sincerely,

Hsu-Heng Yen M.D

Department of Gastroenterology

Changhua Christian Hospital, Taiwan.

###### 

Submitted filename: Response to Reviewer.docx

###### 

Click here for additional data file.

10.1371/journal.pone.0234417.r003
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14 May 2020

PONE-D-20-07441R1

Diagnosis and management of jejunoileal diverticular haemorrhage: an update on the experience in a single centre

PLOS ONE

Dear Dr. Yen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Jun 28 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Chun Chieh Yeh, M.D., Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

Please response our reviewer\'s concerns and make corresponding revisions again.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Dear Authors,

Thanks for your good responses for our reviewer\'s comments

I still have some questions for your manuscript.

Comment 1: The ratio of coexisting duodenal diverticulum or colonic diverticulum is for all patients number. Do your all patients undergo the colonoscopy and EGD before the diagnosis of jejunoileal diverticular bleeding? Because some patients may experience emergency surgery after CT-angiography, small bowel series or enteroscopy (including push endoscopy) without colonoscopy or EGD. Do your raw data have complete EGD and colonoscopy for every patient?

I think the coexisting duodenal or colonic diverticulum is not necessary for your manuscript

Comment 2: You mentioned that your hospital had push enteroscopy and new enteroscopy to diagnose the jejunoileal diverticular bleeding. I suggest your should describe it clearly in your diagnostic modality and your tables.

Best regard

Reviewer \#2: following the major revisions made, I have no comments to the authors.

authors did change the structure of the manuscript in a way that is suitable for retroscpective study. moreover, they introduce the data and the statistics as requested.

they also answer all the questions that I already asked.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: Yes: Jen-Wei Chou

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0234417.r004
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Chun Chieh Yeh, M.D., Ph.D.

Academic Editor
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05/15/2020

Dear Editor,

We appreciate your editorial comments, as well as those of the reviewer Dr. Jen-Wei Chou and reviewer \#2, concerning our revised manuscript. Based on these comments, we have made further revisions to our manuscript, which is resubmitted for your consideration. Your assistance is highly appreciated. We look forward to your message.

The followings are point-by-point responses to the comments:

Reviewer \#1:

Dear Authors,

Thanks for your good responses for our reviewer\'s comments

I still have some questions for your manuscript.

Comment 1: The ratio of coexisting duodenal diverticulum or colonic diverticulum is for all patients number. Do your all patients undergo the colonoscopy and EGD before the diagnosis of jejunoileal diverticular bleeding? Because some patients may experience emergency surgery after CT-angiography, small bowel series or enteroscopy (including push endoscopy) without colonoscopy or EGD. Do your raw data have complete EGD and colonoscopy for every patient?

I think the coexisting duodenal or colonic diverticulum is not necessary for your manuscript.

Response: All authors appreciate the reviewer for the correction very much. According to our raw data, not all of the subjects had undergone colonoscopy or EGD. Therefore, the ratio of coexisting diverticulum we presented based on all patient number was inappropriate. All authors agree with the reviewer's opinion that such data is not necessary for our study, and any content relevant to the "coexisting duodenal or colonic diverticulum" has been removed, as in LINE 87, 117, 191, and in Table 1.

Comment 2: You mentioned that your hospital had push enteroscopy and new enteroscopy to diagnose the jejunoileal diverticular bleeding. I suggest your should describe it clearly in your diagnostic modality and your tables.

Response: All authors thank the reviewer for the suggestion. We think that it is better to be added in the "Materials and Methods" section, as in LINE 90-93: "The methods of enteroscopy include push endoscope (SIF-Q140, Olympus Co., Japan) performed in 5 cases before 2004, and double-balloon endoscope (EN-450P5 or EN-450T5, Fujinon Co., Japan) performed in the rest of the cases after 2004 in our institution."

Reviewer \#2: following the major revisions made, I have no comments to the authors.

authors did change the structure of the manuscript in a way that is suitable for retroscpective study. moreover, they introduce the data and the statistics as requested.

they also answer all the questions that I already asked.

Response: All authors thank the reviewer for reviewing our revised manuscript and the positive feedback. Your assistance is highly appreciated.

Thank you for the opportunity to resubmit this manuscript for consideration of publication in PLOS ONE. If you have any questions or comments regarding this manuscript, please do not hesitate to contact us by mail at our correspondence address, by fax at +886-4-7228289, by telephone at +886-4-7238595ext5501, or by e-mail at <91646@cch.org.tw>

Sincerely,

Hsu-Heng Yen M.D

Department of Gastroenterology

Changhua Christian Hospital, Taiwan.

10.1371/journal.pone.0234417.r005
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27 May 2020
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PONE-D-20-07441R2

Dear Dr. Yen,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Chun Chieh Yeh, M.D., Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thanks for your prompt and appropriate response to the comments raised by our invited reviewers. We consider the manuscript could be accepted at its current content.

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Dear authors,

Thanks for your revisions by my comments. Now, I have no any comments for your manuscript

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

10.1371/journal.pone.0234417.r006
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PONE-D-20-07441R2

Diagnosis and management of jejunoileal diverticular haemorrhage: an update on the experience in a single centre

Dear Dr. Yen:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Chun Chieh Yeh

Academic Editor

PLOS ONE
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